Spire Wealth Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-55
Closed -$7.07K 2426
2023
Q2
$7.07K Hold
55
﹤0.01% 1909
2023
Q1
$9.61K Hold
55
﹤0.01% 1862
2022
Q4
$9K Sell
55
-12
-18% -$1.88K ﹤0.01% 1664
2022
Q3
$9K Sell
67
-2
-3% -$365 ﹤0.01% 1599
2022
Q2
$14K Buy
69
+2
+3% +$438 ﹤0.01% 1802
2022
Q1
$17K Sell
67
-13
-16% -$3.53K ﹤0.01% 1877
2021
Q4
$26K Hold
80
﹤0.01% 2023
2021
Q3
$24K Hold
80
﹤0.01% 1782
2021
Q2
$22K Hold
80
﹤0.01% 1834
2021
Q1
$19K Buy
+80
New +$22K ﹤0.01% 2169

Other funds holding MLAB

Spire Wealth Management's MLAB Position: Q3 2023 in Review

Spire Wealth Management sold out of Mesa Laboratories (MLAB) in Q3 2023, closing a stake of 55 shares — an estimated $7.07K sold.

Spire Wealth Management first reported a position in MLAB in Q1 2021 and held it in 10 quarters. The position peaked at $26K in Q4 2021. 154 funds tracked by Wall St. Rank hold MLAB as of Q3 2023.

  • Spire Wealth Management reported no remaining Mesa Laboratories position as of Q3 2023 after selling out during the quarter.
  • Spire Wealth Management sold 55 Mesa Laboratories shares in Q3 2023, an estimated $7.07K.
  • Spire Wealth Management first reported a position in Mesa Laboratories in Q1 2021 and held it in 10 quarters.
  • Spire Wealth Management's Mesa Laboratories position peaked at $26K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2023.

Based on Spire Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.